An IT strategy for your whole company.

Our focus is regulated industries where technology decisions must survive audit review — healthcare systems and providers (HIPAA, HITECH), insurance carriers and payers (state DOI regimes, SOX for publicly-traded), financial services (SOC 2, PCI-DSS, GLBA), state and federal contractors (FedRAMP, CMMC, FISMA), life sciences (GxP, 21 CFR Part 11), and publicly-traded companies under SOX ITGC. If your regulator is not listed, we can scope applicability and map controls before the engagement starts.

Structurally. We do not resell software, take vendor referral fees, or run a partner program — independence is designed into the business model, not claimed in marketing copy. Our engagement documentation discloses any vendor relationships up front, the scoring criteria are defined before any shortlist is reviewed, and the evaluation matrices are written so your procurement and internal audit teams can verify the reasoning themselves. If your governance process requires a formal independence attestation, we provide it.

A Big-4 technology due diligence is typically optimized for financial control and post-deal accounting. Ours is optimized for regulatory and operational risk inside the technology estate — vendor risk and subprocessor chains, SOC 2 and HIPAA scope gaps, licensing exposure, technical debt that becomes an audit finding, integration cost to your existing control environment, and retention of critical engineering staff through close. We frequently run alongside Big-4 financial due diligence rather than in place of it, and structure the deliverable so both workstreams feed the same investment committee.

Yes. Most mid-market and enterprise CIOs already have a prime consulting relationship — typically one of the Big-4 or a boutique — and bring us in for independent technical review, vendor risk assessment, or regulatory-lens validation on specific decisions. We coordinate scope in writing up front, share deliverables on an agreed cadence, and avoid duplication. The goal is a stronger governance package, not a second opinion for its own sake.

Decision-grade artifacts, not slide decks. Specifically: a sequenced IT roadmap with funding windows and control owners, Architecture Decision Records (ADRs) for every material recommendation, a regulatory-fit matrix mapping each initiative to the HIPAA / SOC 2 / PCI-DSS / SOX obligations it inherits, vendor risk assessments for each recommended technology, investment memos formatted for your audit committee or board, and a target operating model and governance blueprint. Every artifact is designed to be adopted by your team and submitted into your audit evidence file without rework.

We are an advisory service — the deliverable is decisions and documentation, not shipped systems. Many clients engage our security and compliance, cloud, or custom engineering teams for execution once the strategy is approved, because the regulatory framing we establish during the advisory translates cleanly into implementation. You are never obligated. If you prefer to keep implementation internal or with a different partner, the artifacts we produce are designed so any qualified team — internal or external — can execute against them.